Personnel Information

写真a

YOKOMURA Masaru


Job title

Graduate Student

Campus Career 【 display / non-display

  • 2016.04
    -
    2017.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Central Clinical Facilities, Professional Development Center, Trainee Resident
  • 2017.04
    -
    2017.10
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Central Clinical Facilities, Professional Development Center, Resident
  • 2022.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Maxillofacial and Neck Reconstruction, Department of Head and Neck Surgery, Graduate Student
  • 2023.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Maxillofacial and Neck Reconstruction, Head and Neck Surgery, Graduate Student
 

Published Papers & Misc 【 display / non-display

  1. Yuta Hoshi, Satoshi Shirakura, Masato Yamada, Tomonori Sugiyama, Nobuaki Koide, Satoru Tamii, Kyohei Kamata, Masaru Yokomura, Sotaro Osaki, Takafumi Ohno, Kazuhiro Yagihara, Hiroki Hara, Takeshi Beppu. Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab. Int J Clin Oncol. 2023.09; 28 (9): 1139-1146. ( PubMed, DOI )

  2. Takeda, T; Ito, T; Onishi, I; Yokomura, M; Kawashima, Y; Fujikawa, T; Tsutsumi, T. Denosumab-induced osteonecrosis of external auditory canal AURIS NASUS LARYNX. 2021.12; 48 (6): 1199-1203. ( PubMed, DOI )

  3. Takeda Takamori, Ito Taku, Onishi Iichiroh, Yokomura Masaru, Kawashima Yoshiyuki, Fujikawa Taro, Tsutsumi Takeshi. デノスマブで誘発された外耳道の骨壊死(Denosumab-induced osteonecrosis of external auditory canal) Auris・Nasus・Larynx. 2021.12; 48 (6): 1199-1203. ( ichushi )

Conference Activities & Talks 【 display / non-display

  1. 西口 紗英, 横村 優, 永野 誠治, 河本 宏, 高木 聡, 片山 量平. 血小板はCD8陽性T細胞による腫瘍殺傷を抑制する(Platelets inhibit tumor cell killing by antigen-specific CD8 positive T cells). 日本癌学会総会記事 2023.09.01